Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts
Open Access
- 1 December 2011
- journal article
- Published by Springer Science and Business Media LLC in Respiratory Research
- Vol. 12 (1), 57-8
- https://doi.org/10.1186/1465-9921-12-57
Abstract
An imbalance in Matrix MetalloProteases (MMPs) and Tissue Inhibitors of MMPs (TIMPs) contributes to Chronic Obstructive Pulmonary Disease (COPD) development. Longitudinal studies investigating Single Nucleotide Polymorphisms (SNPs) in MMPs and TIMPs with respect to COPD development and lung function decline in the general population are lacking. We genotyped SNPs in MMP1 (G-1607GG), MMP2 (-1306 C/T), MMP9 (3 tagging SNPs), MMP12 (A-82G and Asn357Ser) and TIMP1 (Phe124Phe and Ile158Ile) in 1390 Caucasians with multiple FEV1 measurements from a prospective cohort study in the general population. FEV1 decline was analyzed using linear mixed effect models adjusted for confounders. Analyses of the X-chromosomal TIMP1 gene were stratified according to sex. All significant associations were repeated in an independent general population cohort (n = 1152). MMP2 -1306 TT genotype carriers had excess FEV1 decline (-4.0 ml/yr, p = 0.03) compared to wild type carriers. TIMP1 Ile158Ile predicted significant excess FEV1 decline in both males and females. TIMP1 Phe124Phe predicted significant excess FEV1 decline in males only, which was replicated (p = 0.10) in the second cohort. The MMP2 and TIMP1 Ile158Ile associations were not replicated. Although power was limited, we did not find associations with COPD development. We for the first time show that TIMP1 Phe124Phe contributes to excess FEV1 decline in two independent prospective cohorts, albeit not quite reaching conventional statistical significance in the replication cohort. SNPs in MMPs evidently do not contribute to FEV1 decline in the general population.Keywords
This publication has 29 references indexed in Scilit:
- MMP12,Lung Function, and COPD in High-Risk PopulationsNew England Journal of Medicine, 2009
- Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-α signalingAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Association between markers of emphysema and more severe chronic obstructive pulmonary diseaseThorax, 2006
- Activation of the MMP-1 Promoter by Cigarette Smoke in Human Small Airway Epithelial Cells Requires ERK MAP Kinase Signaling: Differential Response of the 1G and 2G Promoter SequencesProceedings of the American Thoracic Society, 2006
- Elevated MMP-12 protein levels in induced sputum from patients with COPDThorax, 2006
- Decreased macrophage release of TGF- and TIMP-1 in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- The International HapMap ProjectNature, 2003
- Genetic Polymorphism in Matrix Metalloproteinase-9 and Pulmonary EmphysemaBiochemical and Biophysical Research Communications, 2001
- Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN studyThorax, 1998